The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

(Reuters) -The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...

Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new ...

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

"Transparency is important to us at Wildtype." Wildtype is the third lab-grown meat producer to receive full government ...

The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. | The FDA is introducing a ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products ...